First Trust Advisors’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-87,442
Closed -$7.43M 2476
2019
Q4
$7.43M Buy
87,442
+40,440
+86% +$2.7M 0.01% 941
2019
Q3
$2.35M Buy
47,002
+37,777
+410% +$1.51M ﹤0.01% 1448
2019
Q2
$336K Buy
+9,225
New +$301K ﹤0.01% 2262
2016
Q1
Sell
-45,935
Closed -$1.72M 2327
2015
Q4
$1.72M Buy
+45,935
New +$1.74M ﹤0.01% 1471
2015
Q3
Sell
-19,174
Closed -$549K 2359
2015
Q2
$549K Buy
+19,174
New +$534K ﹤0.01% 1968
2014
Q2
Sell
-37,378
Closed -$1.06M 2327
2014
Q1
$1.06M Buy
37,378
+25,795
+223% +$854K ﹤0.01% 1661
2013
Q4
$447K Sell
11,583
-4,849
-30% -$173K ﹤0.01% 1946
2013
Q3
$551K Sell
16,432
-8,380
-34% -$267K ﹤0.01% 1858
2013
Q2
$763K Buy
+24,812
New +$830K 0.01% 1587

Other funds holding MDCO

First Trust Advisors's MDCO Position: Q1 2020 in Review

First Trust Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 87,442 shares — an estimated $7.43M sold.

First Trust Advisors first reported a position in MDCO in Q2 2013 and held it in 9 quarters. The position peaked at $7.43M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • First Trust Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • First Trust Advisors sold 87,442 Medicines Co shares in Q1 2020, an estimated $7.43M.
  • First Trust Advisors first reported a position in Medicines Co in Q2 2013 and held it in 9 quarters.
  • First Trust Advisors's Medicines Co position peaked at $7.43M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on First Trust Advisors's 13F filing for Q1 2020, filed 6 May 2020.